Rely on a trusted lab dedicated to responsible testing

With over 50 years of expertise in diagnostic testing, Quest Diagnostics has been providing insights that can lead to more informed decisions. Our drug testing solutions and approach are making a difference in cost and patient care.

Rely on a trusted lab dedicated to responsible testing

Primary care clinician/NP/PA

Helping to protect your patients and your practice

Primary care clinician/NP/PA

Pain specialists

Helping to ensure patient compliance

Pain specialists

Behavioral health & substance use disorder

Timely insights to inform clinical decisions

Behavioral health & substance use disorder

Health systems & community centers

Balancing clinical benefit with cost

Health systems & community centers

See how inconsistent drug test results compare in your state

An interactive state-by-state overview of patient compliance and inconsistent results

See how inconsistent drug test results compare in your state

Toxicology experts to help interpret results

1.877.40.RXTOX
(1.877.407.9869)

Toxicology experts to help interpret results

Check it out—a new op-ed from Dr. Gudin: Benzodiazepines-Primary Care’s New Drug Problem

Why drug testing matters

When patients misuse opioids, what you see isn’t always what you get. 52% of test results were inconsistent with their prescribed medication regimen.

Why drug testing matters

Why drug testing matters

Drug misuse can happen to anyone, regardless of income or status.

Why drug testing matters

Why drug testing matters

Together we can make a difference in addressing the opioid epidemic and ensuring that patients get access to the care and treatment they need.

Why drug testing matters

Mastering the conversation

Drug monitoring can be a sensitive topic for clinicians and patients alike. Learn more about how to approach the topic with patients.

Mastering the conversation

Latest in drug monitoring

Don’t Withhold Medication-assisted Therapy from Benzodiazepine Users, FDA says

The US Food and Drug Administration has updated its recommendationson co-prescribing benzodiazepines with medication-assisted therapy treatment, stating that buprenorphine and methadone “should not be withheld from patients taking benzodiazepines or other drugs that depress the central nervous system.” While the combination of benzodiazepines or other CNS depressants with…

More stories

2018 Health Trends™ Report

2018 Health Trends Report

Drug Misuse in America 2018—Diagnostic insights from Clinical Drug Monitoring in the opioid epidemic

2018 Health Trends™ Report